Jackson, Grant Investment Advisers, Inc. Amgen Inc Transaction History

Jackson, Grant Investment Advisers, Inc.

  • $246 Million
  • Q2 2024

A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 2,374 shares of AMGN stock, worth $761,009. This represents 0.3% of its overall portfolio holdings.

Number of Shares
2,374
Previous 2,246 5.7%
Holding current value
$761,009
Previous $638,000 16.14%
% of portfolio
0.3%
Previous 0.26%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024
BUY
$262.75 - $319.31 $33,632 - $40,871
128 Added 5.7%
2,374 $741,000
Q3 2023

Oct 13, 2023
SELL
$218.65 - $271.46 $4,810 - $5,972
-22 Reduced 0.97%
2,246 $603,000
Q1 2023

May 02, 2023
BUY
$225.79 - $275.2 $4,967 - $6,054
22 Added 0.98%
2,268 $548,000
Q1 2022

Apr 28, 2022
SELL
$219.27 - $242.57 $39,249 - $43,420
-179 Reduced 7.38%
2,246 $543,000
Q4 2020

Mar 03, 2021
SELL
$216.38 - $257.67 $32,673 - $38,908
-151 Reduced 5.86%
2,425 $558,000
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $469 - $521
2 Added 0.08%
2,576 $655,000
Q2 2020

Aug 14, 2020
BUY
$197.81 - $242.74 $593 - $728
3 Added 0.12%
2,574 $607,000
Q1 2020

May 12, 2020
SELL
$182.24 - $241.7 $1,275 - $1,691
-7 Reduced 0.27%
2,571 $521,000
Q4 2019

Feb 05, 2020
BUY
$189.21 - $243.2 $378 - $486
2 Added 0.08%
2,578 $621,000
Q3 2019

Nov 20, 2019
BUY
$174.11 - $208.62 $348 - $417
2 Added 0.08%
2,576 $498,000
Q2 2019

Aug 13, 2019
BUY
$166.7 - $195.41 $500 - $586
3 Added 0.12%
2,574 $474,000
Q1 2019

May 07, 2019
SELL
$180.87 - $203.88 $723 - $815
-4 Reduced 0.16%
2,571 $488,000
Q4 2018

Jan 23, 2019
BUY
$178.4 - $208.25 $1,605 - $1,874
9 Added 0.35%
2,575 $501,000
Q3 2018

Nov 15, 2018
BUY
$185.29 - $208.89 $370 - $417
2 Added 0.08%
2,566 $532,000
Q2 2018

Aug 02, 2018
BUY
$166.05 - $186.51 $2,988 - $3,357
18 Added 0.71%
2,564 $473,000
Q1 2018

May 14, 2018
BUY
$169.43 - $198.0 $3,049 - $3,564
18 Added 0.71%
2,546 $434,000
Q4 2017

Feb 01, 2018
BUY
$168.79 - $188.59 $374,038 - $417,915
2,216 Added 710.26%
2,528 $440,000
Q3 2017

Nov 14, 2017
SELL
$167.29 - $191.0 $55,038 - $62,839
-329 Reduced 51.33%
312 $58,000
Q2 2017

Aug 10, 2017
BUY
N/A
641
641 $110,000

Others Institutions Holding AMGN

# of Institutions
3,052
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jackson, Grant Investment Advisers, Inc. Portfolio

Follow Jackson, Grant Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson, Grant Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jackson, Grant Investment Advisers, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email